'Virus-like particles (VLPs) as vaccines, vectors and adjuvants', Annecy, France
31 March 2014 - 31 March 2014
France
A conference entitled 'Virus-like particles (VLPs) as vaccines, vectors and adjuvants will be held from 31 March to 2 April 2014 in Annecy, France.
Vaccines are playing a major role in reducing the impact of pathogens, however, alternative approaches are needed if drug development is to improve immunity to infectious diseases.
This meeting poses new questions on antigen design, regarding for instance the optimal and minimal size and structure which are needed for VLPs. It will provide an enriched environment for clinical researchers, pharma companies and healthcare professionals in related disciplines to share research and explore future avenues of collaboration.For further information, please visit:
http://www.fondation-merieux.org/virus-like-particles-vlps-as-vaccines-vectors-and-adjuvants/(opens in new window)
Vaccines are playing a major role in reducing the impact of pathogens, however, alternative approaches are needed if drug development is to improve immunity to infectious diseases.
This meeting poses new questions on antigen design, regarding for instance the optimal and minimal size and structure which are needed for VLPs. It will provide an enriched environment for clinical researchers, pharma companies and healthcare professionals in related disciplines to share research and explore future avenues of collaboration.For further information, please visit:
http://www.fondation-merieux.org/virus-like-particles-vlps-as-vaccines-vectors-and-adjuvants/(opens in new window)